Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Madrid

Madrid 28027

1 studies enrolling now · 3 studies all time

What they study most

Advanced Melanoma, Parkinson's Disease, Idiopathic, Select Advanced Solid Tumors

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD — Completed